Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Main subject
Document Type
Year range
1.
Ter Arkh ; 93(11): 1306-1315, 2021 Nov 15.
Article in Russian | MEDLINE | ID: covidwho-1698700

ABSTRACT

AIM: An analysis of coronavirus infection in Russia and evaluation of different AVT regimens effectiveness. MATERIALS AND METHODS: The study involved a retrospective analysis of 1082 patient records with laboratory-confirmed COVID-19 in 17 regions of Russia. The number of men and women was equal, mean age 48.718.1 (median 50). Patients with moderate COVID-19 (85%) versus mild COVID-19 (15%) were characterized by higher age (median 54 vs 21 years; p0.001), higher body mass index (27.8 vs 23.4; p0.001), prevalence of chronic diseases (75.3% vs 8.5%; p0.001), including circulatory system diseases (37.8%). Moderate COVID-19 characterized higher intoxication (10.86.1 vs 4.22.7 days; p0.001) and catarrhal symptoms duration (10.25.4 vs 6.14.1 days; p0.001). RESULTS: During hospitalization 92% of the patients received AVT, 77% antibiotics, and 16% corticosteroids. Umifenovir therapy resulted in a significant reduction of intoxication (8.75.5 vs 11.75.5 days; p0.001) and catarrhal symptoms duration (8.85.1 vs 12.04.9 days; p0.001) compared to the group without AVT. The usage of INF reduced intoxication symptoms compared with the group without AVT (8.97.5 vs 11.75.5; p0.05). Therapy with hydroxychloroquine, imidazolylethanamide pentandioic acid, and lopinavir + ritonavir combination did not affect the course of COVID-19. Most of adverse reactions were related to antibiotics. CONCLUSION: Umifenovir therapy and inclusion of interferon in AVT regimens was associated improvement in the clinical manifestation of the disease among patients.


Subject(s)
COVID-19 , Male , Humans , Female , Middle Aged , Young Adult , Adult , Lopinavir/therapeutic use , COVID-19/epidemiology , Ritonavir/therapeutic use , Hydroxychloroquine/therapeutic use , SARS-CoV-2 , Retrospective Studies , Antiviral Agents/therapeutic use , Interferons , Anti-Bacterial Agents/therapeutic use
2.
IOP Conference Series. Earth and Environmental Science ; 720(1), 2021.
Article in English | ProQuest Central | ID: covidwho-1182972

ABSTRACT

This article presents a comparative assessment of the various states approaches on the use of funds from their sovereign welfare, an analysis of the sources of the National Welfare funds allocation in Russian Federation. The article provides an approach to assessing the economic efficiency of using the National Welfare Fund of the Russian Federation which is based on a comparative assessment of the rate of returns dynamics with the effective profitability level of foreign sovereign welfare funds. In unstable conditions sharp decline in world oil prices which are associated with a demand contraction of its consumption, mainly due to COVID-19, studies on the formation, distribution and assessment of the effectiveness of the use of states sovereign national welfare funds are timely and relevant.

SELECTION OF CITATIONS
SEARCH DETAIL